Subclinical Thyroid Disease: Clinical Applications
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Subclinical hypothyroidism and hyperthyroidism are diagnoses based on laboratory evaluation with few if any clinical signs or symptoms. Subclinical hypothyroidism is defined as an elevation in serum thyroid-stimulating hormone (TSH) above the upper limit of the reference range (0.45-4.5 mIU/L) with normal serum FT4 concentration; subclinical hyperthyroidism is defined as a decrease in serum TSH below the reference range with normal serum FT4 and T3 concentrations. Though these conditions represent the earliest stages of thyroid dysfunction, the benefits of detecting and treating subclinical thyroid disease are not well established. Most persons found to have subclinical thyroid disease will have TSH values between 0.1 and 0.45 mIU/L or between 4.5 and 10 mIU/L, for which the benefits of treatment are not clearly established; treatment may be beneficial in individuals with serum TSH lower than 0.1 mIU/L or higher than 10 mIU/L. This article illustrates approaches to managing patients with subclinical hypothyroidism and hyperthyroidism through 5 case scenarios that apply the principles of evidence-based medicine. Because of the substantial uncertainty concerning the consequences of untreated subclinical hypothyroidism and hyperthyroidism, as well as the benefit of initiating treatment, patient preferences are important in deciding on management of subclinical disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 1×
“5 and 10 mIU/L.(1,7,8) Routine treatment with levothyroxine is not recommended because data are insufficient to link this degree of hypothyroidism with any adverse health outcomes, and no clear benefits of treatment have been demonstrated.”
BackgroundEffects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398 · cited 1×
“1 mIU/L) carries the potential risks of atrial fibrillation,(15) cardiovascular mortality,(16) and osteoporosis.(17,18) Because these risks are higher among patients older than 60 years, the balance is shifted toward treatment among older patients.”
BackgroundFaber, J., & Galløe, A. M. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300350 · Cited by 377
ROSS, D. S., DANIELS, G. H., & GOUVEIA, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-764 · Cited by 126
Self-citationPersistent Increase in Bone Turnover in Graves’ Patients with Subclinical Hyperthyroidism
Kumeda, Y., Inaba, M., Tahara, H., Kurioka, Y., Ishikawa, T., Morii, H., & Nishizawa, Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6979 · Cited by 123
Cited by
Thyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899
“Despite these ambiguities, policy makers have recommended screening and treatment of subclinical thyroid dysfunction to prevent progression to overt thyroid dysfunction and to improve clinical outcomes, especially in elderly individuals.(12-15) To determine whether subclinical thyroid dysfunction should be treated in…”
BackgroundGeneral Background on the Hypothalamic-Pituitary-Thyroid (HPT) Axis
Zoeller, R. T., Tan, S. W., & Tyl, R. W. (2007) · Critical Reviews in Toxicology · doi:10.1080/10408440601123446 · Cited by 424
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., & McDermott, M. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1231 · Cited by 394
The Thyrotropin Reference Range Should Remain Unchanged
Surks, M. I., Goswami, G., & Daniels, G. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0170 · Cited by 287
Self-citationSubclinical Thyroid Dysfunction and Incident Hip Fracture in Older Adults
Lee, J. S., Bůžková, P., Fink, H. A., Vu, J., Carbone, L., Chen, Z., Cauley, J., Bauer, D. C., Cappola, A. R., & Robbins, J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.424 · Cited by 134
Peeters, R. P. (2008) · Hormones · doi:10.14310/horm.2002.1111035 · Cited by 98
“Subclinical hypothyroidism is by definition a laboratory diagnosis and is defined as an elevated TSH combined with a normal FT4.(44,75) The frequency of subclinical hypothyroidism varies from 4% to 8.”
BackgroundPrevalence of thyroid disease in patients with obstructive sleep apnea
Bahammam, S. A., Sharif, M. M., Jammah, A. A., & BaHammam, A. S. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.07.007 · Cited by 90
Changes in Body Composition in Women Following Treatment of Overt and Subclinical Hyperthyroidism
Greenlund, L. J. S., Nair, K. S., & Brennan, M. D. (2008) · Endocrine Practice · doi:10.4158/ep.14.8.973 · Cited by 56
Schouten, B. J., Brownlie, B. E. W., Frampton, C. M., & Turner, J. G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03908.x · Cited by 55
Cardiovascular risk in elderly hypothyroid patients
Mariotti, S., & Cambuli, V. M. (2007) · Thyroid · doi:10.1089/thy.2007.0130 · Cited by 44
“While substitution therapy with L-T 4 is mandatory in OH, treatment of SH is still a matter of debate (32,34–36).”
Najafi, L., Malek, M., Hadian, A., Ebrahim Valojerdi, A., Khamseh, M. E., & Aghili, R. (2015) · Endocrine Research · doi:10.3109/07435800.2014.896924 · Cited by 41
Papi, G., Pearce, E. N., Braverman, L. E., Betterle, C., & Roti, E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.004 · Cited by 39
Reverter, J. L., Colomé, E., Holgado, S., Aguilera, E., Soldevila, B., Mateo, L., & Sanmartí, A. (2010) · Endocrine · doi:10.1007/s12020-010-9339-z · Cited by 37
Buscemi, S., Verga, S., Cottone, S., Andronico, G., D’Orio, L., Mannino, V., Panzavecchia, D., Vitale, F., & Cerasola, G. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03347430 · Cited by 35
Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin
Rose, S. R. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.047 · Cited by 27
Ahn, D., Lee, G. J., & Sohn, J. H. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07786-x · Cited by 27
Karmisholt, J., Andersen, S., & Laurberg, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0101 · Cited by 19
Metadata
- Authors
- Col, N. F., Surks, M. I., & Daniels, G. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-14
- Volume
- 291
- Issue
- 2
- Pages
- 239
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2023982075
- Cited by
- 194
- References
- 9
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.